Genetics of Spontaneous Intracerebral Hemorrhage

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
- cerebral hemorrhage
- genetics
- genetics, population
- genome-wide association study
- polymorphism, single nucleotide
The epidemiology of spontaneous intracerebral hemorrhage (ICH) has rapidly progressed in the past few decades, with important genetic and nongenetic discoveries.1 Hypertension has long been associated with ICH, and evidence now demonstrates that untreated hypertension produces substantial increases in risk of this condition.2,3 Unlike cardiovascular disease, cholesterol is inversely associated with ICH, with low levels of total and low-density lipoprotein cholesterol having an association with increased risk.4,5 Along these lines, the SPARCL study (Stroke Prevention by Aggressive Reduction in Cholesterol Levels)6 demonstrated that in secondary prevention of ischemic stroke, statin use was associated with a small increase in risk of ICH although large meta-analyses did not confirm this correlation in the general population.7 Moderate alcohol consumption has consistently been identified as associated with a lower ICH risk whereas heavy alcohol consumption has been found to associate with an elevated risk of this condition.8 Anticoagulant treatment, largely in relationship to warfarin use, has also been consistently associated with ICH risk with a particular predilection for cerebellar ICH.9,10 Finally, cerebral amyloid angiopathy (CAA), first recognized as an ICH mechanism in the 1990s, is a common feature of lobar hemorrhages.11
Although these risk factors explain an important proportion of the variance in ICH risk, a significant portion of this variation remains unexplained. In addition, in the absence of proven acute treatments for ICH, novel targets for therapeutic interventions are urgently needed. Population genetics can contribute to solve these 2 unanswered questions as heritability estimates based on genome-wide data from unrelated individuals indicate that up to 30% of ICH risk can be explained by common and rare genetic variation.12 Furthermore, through studies that combine environmental and genetic risk factors, genomic analysis can also help us understand how individual susceptibility …
American Heart Association Professional?
Log in using your username and password
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Jump to
- Article
- Paradigm Shift: Candidate Gene to Genome-Wide and Sequencing Studies
- Technical and Analytic Terms
- Phenotyping Based on Biology
- Epsilon Variants Within APOE: an Unusually Strong Genetic Risk Factor for ICH
- 1q22: The First Nonfamilial Genetic Risk Factor for Deep ICH
- COL4A1 and COL4A2: an Example of Rare and Common Genetic Contribution to ICH Risk
- Mendelian (Monogentic) Diseases That Manifest With ICH
- Clinical Implications
- Future Directions
- Sources of Funding
- Disclosures
- References
- Figures & Tables
- Info & Metrics
- eLetters
This Issue
Jump to
- Article
- Paradigm Shift: Candidate Gene to Genome-Wide and Sequencing Studies
- Technical and Analytic Terms
- Phenotyping Based on Biology
- Epsilon Variants Within APOE: an Unusually Strong Genetic Risk Factor for ICH
- 1q22: The First Nonfamilial Genetic Risk Factor for Deep ICH
- COL4A1 and COL4A2: an Example of Rare and Common Genetic Contribution to ICH Risk
- Mendelian (Monogentic) Diseases That Manifest With ICH
- Clinical Implications
- Future Directions
- Sources of Funding
- Disclosures
- References
- Figures & Tables
- Info & Metrics
Article Tools
- Genetics of Spontaneous Intracerebral HemorrhageGuido J. Falcone and Daniel WooStroke. 2017;48:3420-3424, originally published November 7, 2017https://doi.org/10.1161/STROKEAHA.117.017072
Citation Manager Formats